
Publication
Cannabis’ legalization and what it means for regulatory regimes worldwide
Cannabis has been considered an illegal substance globally since the creation of the Single Convention on Narcotic Drugs (The Convention) in 1961.
Global | Publication | October 2020
Our global Food and Agribusiness team has a deep understanding of the existing and emerging issues surrounding the global cannabis industry. Cannabis is a sector in a state of rapid transition globally, as numerous countries and states have legalized its use for either recreational or medicinal purposes in recent years. This creates a myriad of opportunities and challenges for companies considering investment in the sector, particularly in relation to investments across multiple jurisdictions. Find out what’s new in this developing industry sector.

Publication
Cannabis has been considered an illegal substance globally since the creation of the Single Convention on Narcotic Drugs (The Convention) in 1961.

Publication
The maturation of the cannabis sector is presenting an array of opportunities to private producers and retailers.

Publication
In the 12 months leading to legalization in October 2018, Canadian public companies already in the medical cannabis space experienced “jaw-dropping growth” in their market capitalizations, notwithstanding that many reported negative earnings.

Publication
The cannabis sector is a growing and exciting sector.
Publication
Since the 2024 amendments to Ontario’s Construction Act under Schedule 4 of Bill 216 (Building Ontario For You Act (Budget Measures), 2024) received royal assent, project owners and construction companies have been holding their breath for the amendments to come into force.
Publication
The Sustainable Harnessing and Advancement of Nuclear Energy Act, 2025 (the SHANTI Act) came into effect in India on 21 December 2025. The SHANTI Act is the most sweeping reform of India’s nuclear regime to date, repealing the previously existing Atomic Energy Act, 1962 and the Civil Liability for Nuclear Damage Act, 2010 (CLND Act).
Publication
2025 marked a turning point for UK private equity, and as we look to 2026, industry participants anticipate a further uptick in deal activity, particularly in the mid-market, but caution remains essential as competition intensifies and regulatory scrutiny grows.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2025